secwatch.observer — SEC 8-K summary
======================================

Issuer:     Acutus Medical, Inc. (—)
CIK:        0001522860
Form:       8-K
Filed at:   2024-12-04T23:59:59+00:00
Accession:  0000950103-24-017271
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 2.05, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Acutus Medical cuts 70% workforce (~61 employees) and transitions CEO to consulting role
--------------------------------------------------------------------------------

- Workforce reduction of ~61 employees (~70%) expected to be completed by Q1 2025.
- Pre-tax exit charges estimated $1.4M-$1.8M; majority cash outlay in Q1 2025.
- CEO Takeo Mukai shifts to consulting role Feb 2025, retains titles, receives $10k/month.
- Company scales down to only support Medtronic left-heart access obligations; earnout potential until 2027.
- Cash on hand $12.6M as of Sep 30, 2024, expected to fund remaining business.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1522860/000095010324017271/0000950103-24-017271-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1522860/000095010324017271/dp221457_8k.htm
  HTML page:      https://secwatch.observer/filing/0000950103-24-017271

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer